Back
JPMorgan Chase & Vs. Monopar Therapeutics Industry Stock Comparison
Buy
62
JPM
JPMorgan Chase &
Last Price:
$226.77
Seasonality Move:
2.07%
Sell
31
MNPR
Monopar Therapeutics
Last Price:
$32.67
Seasonality Move:
-9.44%
Buy
62
JPMorgan Chase & (JPM)
is a Buy
Is JPMorgan Chase & a Buy, Sell or Hold?
-
The current JPMorgan Chase & [JPM] share price is $234.34. The Score for JPM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
JPM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $32.62. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JPM Stock Price Chart
What is JPMorgan Chase &'s stock price today?
-
The JPMorgan Chase & share price today is $234.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JPM is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $32.62Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
JPM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.14 | Sell |
Relative Strength Index (14 RSI): | 47.04 | Sell |
Chaikin Money Flow: | 18136909 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.23 | Sell |
Relative Strength Index (14 RSI): | 46.8 | Sell |
Chaikin Money Flow: | 15857 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
JPM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 229.93 | Buy |
20-day SMA: | 236.34 | Sell |
50-day SMA: | 252.65 | Sell |
200-day SMA: | 230.74 | Buy |
8-day EMA: | 228.69 | Buy |
20-day EMA: | 236.2 | Sell |
50-day EMA: | 244.21 | Sell |
200-day EMA: | 230.95 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.92 | Sell |
20-day SMA: | 35.5 | Sell |
50-day SMA: | 37.99 | Sell |
200-day SMA: | 18.2 | Buy |
8-day EMA: | 32.75 | Sell |
20-day EMA: | 34.54 | Sell |
50-day EMA: | 34.49 | Sell |
200-day EMA: | 22.59 | Buy |
JPMorgan Chase & Earnings Growth & JPM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.20 per share, a decrease this year of $0.06 per share, and an increase next year of $1.26 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.86 per share, and an increase next year of $0.69 per share.
JPMorgan Chase & Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |